Subheading · Section VI
3006.93: Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses
- FreeUK
- FreeEU
- 50%Türkiye
- 0%–6.4%USA
- US$1.6bnWorld trade in 2024
3006.93 is a six-digit subheading of heading 3006, pharmaceutical goods specified in note 4 to this chapter, chapter 30.
Subheading 3006.93 is a single line in the UK Global Tariff, where the duty is duty-free.
The EU Combined Nomenclature has one tariff line for subheading 3006.93; the duty is duty-free.
Subheading 3006.93 is a single line in the Turkish Customs Tariff Schedule, where the statutory rate is 50%.
The Harmonized Tariff Schedule of the United States divides subheading 3006.93 into 5 tariff lines; the duty is between 0% and 6.4% (average 3.8%). 1 of them is duty-free. 2 lines have a specific or compound duty.
World trade in these goods reached US$1.6bn in 2024, up 27.9% on 2023.
The United States was the largest exporter with 22.6% of the total, ahead of Ireland.
Malaysia imported the most (US$466.4m).
The United Kingdom ranked 6th among 107 exporters with US$86.2m; its largest buyer was Malaysia.
The United Kingdom imported US$70m, most of it from the United States.
Duty rates compared
UK Free Third-country duty 1 tariff line 
EU Free Third-country duty 1 tariff line 
Türkiye 50% Statutory rate (Law 474) 1 tariff line 
USA Free – 6.4% General (MFN) 5 tariff lines · average 3.8% · 2× specific or compound duty The Turkish schedule prints the statutory rate set under Customs Law 474. The rate applied at import is laid down in the Import Regime Decision and can be lower, or different by country of origin.
UK Global Tariff
UK lines →- 3006 93 00 00 Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses Free
EU Combined Nomenclature
EU lines →- 3006 93 00 Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses Free—
Turkish Customs Tariff Schedule
Türkiye lines →This line has no official text in this language; it is shown in the language of its tariff.
- 3006.93.00.00.00 Tanınmış klinik çalışmalarda kullanılmak üzere plasebolar ve kör (veya çift kör) klinik deney kitleri (ölçülü dozlarda) 50%
Harmonized Tariff Schedule of the United States
USA lines →- 3006.93 Placebos and blinded (or double-blinded) clinical trial kits for a recognized clinical trial, put up in measured doses:
- 3006.93.10.00 Packaged with medicinal preparations Freekg
- 3006.93.20.00 Containing over 10 percent by dry weight of sugar 40¢/kg + 10.4%kg
- 3006.93.50.00 Containing ingredients having nutritional value, in which starch or other foodstuff predominates by weight 6.4%kg
- 3006.93.60.00 In liquid form for oral intake 0.2¢/literliters
- 3006.93.80.00 Placebos and clinical trial kits containing other chemicals other than medicaments 5%kg
Special: reduced rates under trade agreements and preference programmes; the letters in brackets name the programmes (for example AU = Australia FTA, KR = Korea FTA).
World trade in 2024
Trade value (US$) no reported trade < US$361.8kUS$361.8k+US$9.7m+US$78.6m+> US$97m
Exports: 107
- United States: US$365.4m
- Ireland: US$114.4m
- Malaysia: US$97m
- India: US$95.5m
- Switzerland: US$95.1m
- United Kingdom: US$86.2m
- France: US$83.7m
- Italy: US$83.1m
- Canada: US$81.8m
- Germany: US$78.6m
- Belgium: US$77m
- China: US$52.8m
- Denmark: US$48.3m
- Japan: US$30.9m
- Spain: US$28.8m
- Sweden: US$18.7m
- Thailand: US$17.7m
- Taiwan: US$16.5m
- Slovenia: US$13.4m
- Austria: US$12.9m
- Netherlands: US$12.4m
- Australia: US$11.5m
- South Korea: US$11.1m
- Singapore: US$10.3m
- Greece: US$9.7m
- Brazil: US$9m
- Indonesia: US$7.4m
- Portugal: US$6.7m
- Mexico: US$5.2m
- Hong Kong SAR China: US$5m
- Hungary: US$4.4m
- Vietnam: US$3.7m
- Finland: US$3.3m
- Poland: US$2.9m
- Türkiye: US$2.1m
- South Africa: US$1.8m
- Cyprus: US$1.7m
- Czechia: US$1.6m
- Bulgaria: US$1.1m
- Romania: US$1m
- Bangladesh: US$972.8k
- Malta: US$851.4k
- New Zealand: US$825k
- Egypt: US$745.1k
- Norway: US$583.3k
- Pakistan: US$504.5k
- Philippines: US$403.7k
- Israel: US$382.9k
- Croatia: US$370.8k
- Slovakia: US$361.8k
- New Caledonia: US$347.3k
- Chile: US$300.3k
- Lithuania: US$269.5k
- Ukraine: US$244.3k
- Serbia: US$182.5k
- United Arab Emirates: US$162.4k
- Argentina: US$154.9k
- Russia: US$148.8k
- Kenya: US$100.9k
- Estonia: US$98.9k
Trade value (US$) no reported trade < US$243.6kUS$243.6k+US$2.7m+US$21.8m+> US$67.2m
Imports: 180
- Malaysia: US$466.4m
- United States: US$172.7m
- China: US$84.4m
- Japan: US$73.8m
- United Kingdom: US$70m
- Germany: US$67.2m
- Belgium: US$62.4m
- Switzerland: US$54.5m
- Canada: US$52m
- South Korea: US$36.1m
- Netherlands: US$36.1m
- Australia: US$32.2m
- Ireland: US$27.3m
- Singapore: US$24.4m
- Brazil: US$23.4m
- Philippines: US$22.4m
- Israel: US$22.4m
- Taiwan: US$21.8m
- Brunei: US$19.4m
- Mexico: US$18m
- Italy: US$16.9m
- Argentina: US$12.7m
- Türkiye: US$12.5m
- South Africa: US$12.4m
- India: US$11.9m
- Thailand: US$10.6m
- Hong Kong SAR China: US$9.9m
- Serbia: US$9.5m
- Chile: US$9.4m
- Ukraine: US$8.8m
- New Zealand: US$6.9m
- Nigeria: US$6.8m
- Colombia: US$6.4m
- Russia: US$6.1m
- France: US$5.6m
- Cambodia: US$5.5m
- Sweden: US$5.3m
- Kenya: US$4.5m
- Saudi Arabia: US$3.7m
- Slovakia: US$3.6m
- Georgia: US$3.5m
- Austria: US$3.2m
- Jordan: US$3.2m
- Bulgaria: US$2.7m
- Vietnam: US$2.7m
- Poland: US$2.6m
- Peru: US$2.5m
- Denmark: US$2.3m
- Norway: US$2.2m
- Ghana: US$2m
- Slovenia: US$1.9m
- Myanmar (Burma): US$1.7m
- United Arab Emirates: US$1.7m
- Sri Lanka: US$1.7m
- Spain: US$1.4m
- Belarus: US$1.3m
- Guatemala: US$1.2m
- Iraq: US$1.2m
- Mauritius: US$1.1m
- Maldives: US$1.1m
Top exporters
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | United States | US$365.4m | 22.6% |
| 2 |  Ireland | US$114.4m | 7.1% |
| 3 |  Malaysia | US$97m | 6% |
| 4 |  India | US$95.5m | 5.9% |
| 5 |  Switzerland | US$95.1m | 5.9% |
| 6 | United Kingdom | US$86.2m | 5.3% |
| 7 |  France | US$83.7m | 5.2% |
| 8 |  Italy | US$83.1m | 5.1% |
| 9 |  Canada | US$81.8m | 5.1% |
| 10 |  Germany | US$78.6m | 4.9% |
Top importers
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | Malaysia | US$466.4m | 28.8% |
| 2 | United States | US$172.7m | 10.7% |
| 3 |  China | US$84.4m | 5.2% |
| 4 |  Japan | US$73.8m | 4.6% |
| 5 | United Kingdom | US$70m | 4.3% |
| 6 | Germany | US$67.2m | 4.2% |
| 7 |  Belgium | US$62.4m | 3.9% |
| 8 | Switzerland | US$54.5m | 3.4% |
| 9 | Canada | US$52m | 3.2% |
| 10 |  South Korea | US$36.1m | 2.2% |
Questions and answers
What is the HS code for placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses?
Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses fall under HS subheading 3006.93, part of heading 3006, in section VI of the Harmonized System.
What is the import duty on placebos and blinded in the UK?
Under the UK Global Tariff, imports under 3006.93 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
What is the import duty on placebos and blinded in the EU?
Under the EU Combined Nomenclature, imports under 3006.93 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
Which country exports the most placebos and blinded?
The United States, with US$365.4m in 2024 (22.6% of world exports).